The pharmaceutical intermediate sub-industry can be further divided into CRO and CMO industries.

- Dec 11, 2018 -

The pharmaceutical intermediate sub-industry can be further divided into CRO and CMO industries.



CMO: Contract ManufacturingOrganization refers to manufacturing enterprise of the agency Contract, means that pharmaceutical companies will be outsourced manufacturing partners. The business chain of the pharmaceutical CMO industry generally starts from specialized pharmaceutical raw materials. Industrial companies need to purchase basic chemical raw materials and classify them into special medical raw materials, and then gradually form raw material of API, intermediate of cGMP, API and preparation. At present, major multinational pharmaceutical companies tend to establish long-term strategic partnership with a few core suppliers, and the survival of companies in the industry is basically obvious through their partners.



CRO: Contract (Clinical)Research Organization is a Clinical practice in which a pharmaceutical company subcontracts Research to a partner. At present the industry mainly to customize production, custom research and development as well as the medical contract research and sales as the main method of cooperation, either way, whether or not pharmaceutical intermediates products for innovative products, judge the enterprise's core competitiveness is still in research and development technology for the first element, lateral reflection for the company's downstream customers or partners.


Related Industry Knowledge

Related Products

  • CAS:96034-64-9
  • Dodecylbenzenesulfonyl Azide 79791-38-1
  • 4-nitrobenzyl 2-diazo-3-oxobutanoate
  • C4H4O3
  • 2-Amino-9,9-Dimethylfluorene 108714-73-4
  • C15H15N